financially supported by the National Natural Science Foundation of China(Nos.51873120,51673127,and 81621003);Department of Science and Technology of Sichuan Province(Nos.2018JY0574,2017SZ0006,18GJHZ0139,and 2018HH0006,China);1·3·5 Research Funds in West China Hospital of Sichuan University(ZYGD18028,China)
Multi-modal therapeutics are emerging for simultaneous diagnosis and treatment of cancer.Polymeric carriers are often employed for loading multiple drugs due to their versatility and controlled release of these drugs ...
Project supported by the Zhejiang Provincial Natural Science Foundation of China(No.LY14H160016)。
To reduce the problems of poor solubility,high in vivo dosage requirement,and weak targeting ability of paclitaxel(PTX),a hyaluronic acid-octadecylamine(HA-ODA)-modified nano-structured lipid carrier(HA-NLC)was constr...
financially supported by the National Nature Science Foundation of China (No. 81703451);the China Postdoctoral Science Foundation (No. 2017M611269 and 2018T110233)
Self-nanoemulsifying drug delivery system(SNEDDS) has emerged as a promising platform to improve oral absorption of drugs with poor solubility and low permeability. However,large polarity molecules with insufficient l...
National Natural Science Foundation of China(Grant No.81172992);the National Key Research and Development Program of China(Grant No.2017YFA0205600)
In the present study, we prepared the iRGD-modified lysolipid-containing thermosensitive liposomes(LTSL) containing conjugated linoleic acid-paclitaxel(CLA-PTX), also known as iRGD-LTSL-CLA-PTX. The in vitro cellular ...